8 March 2021
The importance of manufacturing agility and supply resilience in the biopharma industry regionally
A joint collaboration between Financial Times and Cytiva, the Global Biopharma Resilience Index assesses the biopharma capabilities and resilience of 20 countries across the world following the Covid-19 pandemic crisis. The Index provides ways in which countries can learn from each other to futureproof to tackle the challenges now and beyond the pandemic. Francis Van Parys, Vice President, Asia Pacific, Cytiva shares more about Cytiva's brand transformation journey and what the biopharma industry in Singapore and the region is currently like.

Download the podcast.